CONCERT: A PHASE 3 MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TWELVE-MONTH SAFETY AND EFFICACY STUDY EVALUATING DIMEBON IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER'S DISEASE ON DONEPEZIL Contract uri icon

Overview

Grant awarded by

  • NOVOTECH (AUSTRALIA) PTY LTD

Awards

Time

Date/time interval

  • 2009 -